All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

An expert panel hosted by

Customizing first-line BTK inhibitors for CLL

with Gilles Salles, Paolo Ghia, and Francesc Bosch

Wednesday, October 23, 2024
18:30-19:30 BST

Register now

This independent educational activity is supported by Pharmacyclics LLC, an AbbVie Company and Janssen Biotech. All content is developed independently by the faculty. The funder is allowed no influence on the content of this activity.

  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2023-08-25T13:52:08.000Z

New NCCN guidelines for pediatric patients with Hodgkin lymphoma and their families

Aug 25, 2023
Share:
Learning objective: After reading this article, learners will be able to provide families with a new resource for pediatric Hodgkin lymphoma.

The National Comprehensive Cancer Network (NCCN) has published guidelines for pediatric patients with Hodgkin lymphoma and their families; the guidelines provide a clear explanation of all aspects of the disease, including:

  • diagnosis and testing
  • staging
  • treatment options
  • follow-up care

The book will also feature organizations and contacts to connect families and provide personalized support for every step of the decision process.

NCCN guidelines

NCCN guidelines are evidence-based recommendations developed by a panel of experts from leading NCCN Member Institutions, they are frequently updated and contain detailed clinical practice recommendations for several cancer types. These new guidelines are aimed at pediatric patients diagnosed with Hodgkin lymphoma and their caregivers. They include,

  • charts and images;
  • a glossary of medical terms; and
  • questions to ask during appointments.

As pediatric Hodgkin lymphoma is a rare cancer, this guide will disseminate peer-reviewed guidance that patients and families can refer to for accurate, accessible information.

  1. PR Newswire. NCCN releases new resource to help families understand pediatric Hodgkin lymphoma, part of award-winning patient information series. https://www.prnewswire.com/news-releases/nccn-releases-new-resource-to-help-families-understand-pediatric-hodgkin-lymphoma-part-of-award-winning-patient-information-series-301906740.html#:~:text=The%20book%20offers%20a%20comprehensive,rates%20of%2090%25%20or%20higher. Published August 22, 2023. Accessed August 2023.

Understanding your specialty helps us to deliver the most relevant and engaging content.

Please spare a moment to share yours.

Please select or type your specialty

  Thank you

Your opinion matters

HCPs, what is your preferred format for educational content on the Lymphoma Hub?
6 votes - 53 days left ...

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox